Chart Check: AstraZeneca Pharma gives breakout from 7-month consolidation phase; where is the stock headed?Experts predict that AstraZeneca Pharma's stock price may hit 4000 levels in the next month after breaking out from a 7-month-long consolid...
16 Jun, 2023, 11.55 AM IST
AstraZeneca Pharma gains despite fall in Q2 profit; here's whyIn the July-September quarter, AstraZeneca Pharma India reported a decline of 54.65 per cent in net profit to Rs 11.94 crore. In the same p...
10 Nov, 2021, 10.26 AM IST
AstraZeneca Pharma gets DCGI nod to market asthma drugAstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt ...
21 Dec, 2020, 11.47 AM IST
AstraZeneca Pharma India Q1 results: Net profit declines 13% at Rs 18.63 croreDrug firm AstraZeneca Pharma India on Monday reported a 13.38 per cent decline in its net profit to Rs 18.63 crore for the quarter ended Ju...
10 Aug, 2020, 04.28 PM IST
AstraZeneca Pharma India gets DCGI nod to market diabetes drugThe product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca...
17 Oct, 2017, 06.01 PM IST
AstraZeneca Pharma India appoints Gagan Singh Bedi as MDThe company has accepted resignation of Sanjay Murdeshwar as MD and as a director. He is shifting to a global role within the AstraZeneca g...
29 Jun, 2017, 07.33 PM IST
AstraZeneca Pharma India to close Bengaluru API unitDrug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient (API) unit at Bengaluru due to low demand for the produc...
03 Dec, 2015, 05.51 PM IST
AstraZeneca Pharma board approves delisting of company's shares from stock exchangesAstraZeneca Pharma today said its board has approved delisting of the company's shares from bourses, including BSE and the National Stock E...
18 Mar, 2014, 10.44 PM IST
AstraZeneca Pharma shares rise 3 per cent on board's approved delisitngShares of AstraZeneca Pharma rose by 3 per cent as its board has approved delisting of the company's shares from bourses like NSE, BSE etc.
18 Mar, 2014, 06.08 PM IST
- Buy AstraZeneca Pharma Ltd with target price of Rs 1020: Sandeep Wagle
AstraZeneca Pharma Ltd is a 'BUY' call with a target of Rs 1020 and a stop loss of Rs 884.
03 Mar, 2014, 11.23 AM IST
AstraZeneca up 20% on delisting proposal, locked in upper circuit at Rs 1,110.90AstraZeneca said in the filing before markets opened on Monday that its board received a request from its promoter to initiate a voluntary ...
03 Mar, 2014, 11.22 AM IST
- Buy AstraZeneca Pharma India Ltd with a target of Rs 870: Ashwani Gujral
"AstraZeneca Pharma India Ltd is a ‘BUY’ call with a target of Rs 870 and a stop loss of Rs 825."
27 Aug, 2013, 08.45 AM IST
- Buy AstraZeneca Pharma with target price of Rs 930: Ashwani Gujral
AstraZeneca Pharma Ltd is a 'BUY' call with a target of Rs 930 and a stop loss of Rs 850.
16 Aug, 2013, 09.51 AM IST
- Buy Astrazeneca Pharma with target price of Rs 960: Prakash Gaba
Buy Astrazeneca Pharma at a stop of Rs 807.
30 May, 2013, 11.35 AM IST
- AstraZeneca Pharma promoter to sell stake in Indian arm
AstraZeneca India today said its promoter AstraZeneca Pharmaceuticals AB Sweden plans to offload around 37 lakh shares through offer for sa...
24 May, 2013, 07.56 PM IST
- Buy AstraZeneca Pharma with a target of 1860: Sandeep Wagle
AstraZeneca Pharma India Ltd is a ‘BUY’ call with a target of Rs 1860 and a stop loss of Rs 1680.
22 Aug, 2012, 10.07 AM IST
- AstraZeneca Pharma to delist from India; shares jump 20 pc
AstraZeneca Pharma India today said it will de-list itself from domestic stock exchanges, fueling a jump of 20 per cent in its stock price ...
29 Jun, 2010, 02.27 PM IST